Scaffold-switching: An exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates

Por Moraski, Garrett C., Oliver, Allen G., Markley, Lowell D., Cho, Sanghyun, Franzblau, Scott G., Miller, Marvin J.
Publicado em 2014

Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity

Por Moraski, Garrett C., Markley, Lowell D., Hipskind, Philip A., Boshoff, Helena, Cho, Sanghyun, Franzblau, Scott G., Miller, Marvin J.
Publicado em 2011

Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fus...

Por Moraski, Garrett C., Markley, Lowell D., Chang, Mayland, Cho, Sanghyun, Franzblau, Scott G., Hwang, Chang Hwa, Boshoff, Helena, Miller, Marvin J.
Publicado em 2012

Characterization of the Anopheles gambiae octopamine receptor and discovery of potential agonists and antagonists using a combined computational-experimental approach

Por Kastner, Kevin W, Shoue, Douglas A, Estiu, Guillermina L, Wolford, Julia, Fuerst, Megan F, Markley, Lowell D, Izaguirre, Jesús A, McDowell, Mary Ann
Publicado no Malar J (2014)

Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis

Por Moraski, Garrett C., Markley, Lowell D., Cramer, Jeffrey, Hipskind, Philip A., Boshoff, Helena, Bailey, Mai A., Alling, Torey, Ollinger, Juliane, Parish, Tanya, Miller, Marvin J.
Publicado em 2013